Related Experiment Video
Updated: Aug 2, 2026

Intramyocardial Cell Delivery: Observations in Murine Hearts
Published on: January 24, 2014
Stem cells for the heart, are we there yet?
F Timmermans1, J De Sutter, T C Gillebert
1Department of Cardiovascular Diseases, Ghent University, Ghent, Belgium. timmermansfrank1973@hotmail.com
Insights
Bone marrow stem cells show promise for repairing heart damage after myocardial infarction. This therapy could prevent heart failure, offering a new strategy for cardiac regeneration in humans.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
- Stem Cell Therapy
Background:
- Despite advances, myocardial infarction (MI) complications like chronic heart failure remain a significant global health issue.
- Existing cardiac repair mechanisms are insufficient to prevent heart disease in most pathological conditions.
- Post-MI heart failure continues to be a major worldwide health concern.
Purpose of the Study:
- To review the potential of bone marrow stem cells for cardiac regeneration following myocardial infarction.
- To discuss critical considerations for future human clinical trials involving stem cell therapy for heart repair.
Main Methods:
- Review of existing scientific literature on stem cell therapy and cardiac regeneration.
- Analysis of evidence supporting bone marrow stem cell differentiation into cardiomyocytes.
- Discussion of challenges and opportunities in translating stem cell therapy to human trials.
Main Results:
- Growing evidence suggests bone marrow stem cells, including mesenchymal stem cells, can generate new cardiomyocytes in both animal models and humans.
- Stem cell therapy presents a promising strategy to restore cardiac function after MI and prevent congestive heart failure.
- Key issues for human trials regarding efficacy and safety are being identified.
Conclusions:
- Bone marrow stem cell therapy holds significant potential for treating myocardial infarction and preventing heart failure.
- Further research and careful consideration of issues are paramount for successful human clinical trials in cardiac regeneration.
- Stem cell therapy represents a promising frontier in cardiovascular medicine for heart repair.
Abstract:
Although several repair mechanisms have been described in the human heart, all fall too short to prevent clinical heart disease in most acute or chronic pathological cardiac conditions. Moreover, despite many breakthroughs in cardiovascular medicine, the complications of a myocardial infarction such as chronic heart failure remains a serious worldwide problem. Bone marrow stem cells could provide for a promising strategy to restore myocardial infarctions and prevent postinfarct congestive heart failure, because there is growing body of evidence that bone marrow stem cells, such as mesenchymal stem cells, can generate new cardiomyocytes in animals and humans. In this review, we will discuss important issues on stem cell therapy for cardiac regeneration after myocardial infarction, which might be of paramount importance when considering future human trials.
Related Concept Videos
Embryonic Stem Cells
Induced Pluripotent Stem Cells
Stem Cell Culture
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
iPS Cell Differentiation

